1-12 of 12
exenatide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?

Open Access
Robert H. Eckel, Azeez Farooki, Robert R. Henry, Gary G. Koch, Lawrence A. Leiter
Journal: Clinical Diabetes
Clin Diabetes 2019;37(4):316–337
https://doi.org/10.2337/cd19-0001
Published: 01 October 2019
View article titled, Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?
Open the PDF for Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice? in another window
Journal Articles

ITCA 650

Open Access
Taylor Bertsch, Kimberly McKeirnan
Journal: Clinical Diabetes
Clin Diabetes 2018;36(3):265–267
https://doi.org/10.2337/cd18-0039
Published: 01 July 2018
View article titled, ITCA 650
Open the PDF for ITCA 650 in another window
Journal Articles

Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists

Free
Mansur Shomali, MD, CM
Journal: Clinical Diabetes
Clin Diabetes 2014;32(1):32–43
https://doi.org/10.2337/diaclin.32.1.32
Published: 01 January 2014
View article titled, Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists
Open the PDF for Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists in another window
Journal Articles

Using Bydureon

Free
Journal: Clinical Diabetes
Clin Diabetes 2012;30(3):134
https://doi.org/10.2337/diaclin.30.3.134
Published: 01 July 2012
View article titled, Using Bydureon
Open the PDF for Using Bydureon in another window
Journal Articles

Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects

Free
Charles F. Shaefer, Jr., MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(3):92–94
https://doi.org/10.2337/diaclin.30.3.92
Published: 01 July 2012
View article titled, Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects
Open the PDF for Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects in another window
Journal Articles

Once-Weekly Glucose-Lowering Therapy for Type 2 Diabetes

Free
Susan LaRue, RD, CDE, Mary Beth DeYoung, PhD, Amy Blickensderfer, PharmD, Steve Chen, MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(3):95–100
https://doi.org/10.2337/diaclin.30.3.95
Published: 01 July 2012
View article titled, Once-Weekly Glucose-Lowering Therapy for Type 2 Diabetes
Open the PDF for Once-Weekly Glucose-Lowering Therapy for Type 2 Diabetes in another window
Journal Articles

The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?

Free
Lisa S. Rotenstein, BA, Benjamin M. Kozak, BA, Joseph P. Shivers, BA, Mark Yarchoan, BA, John Close, MBA, Kelly L. Close, MBA
Journal: Clinical Diabetes
Clin Diabetes 2012;30(2):44–53
https://doi.org/10.2337/diaclin.30.2.44
Published: 01 April 2012
View article titled, The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?
Open the PDF for The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We? in another window
Journal Articles

Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence

Free
Timothy Reid, MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(1):3–12
https://doi.org/10.2337/diaclin.30.1.3
Published: 01 January 2012
View article titled, Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence
Open the PDF for Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence in another window
Journal Articles

Application of Adult-Learning Principles to Patient Instructions: A Usability Study for an Exenatide Once-Weekly Injection Device

Free
Gayle Lorenzi, RN, CDE, Barbara Schreiner, PhD, Joachim Osther, Marilyn Boardman, PharmD
Journal: Clinical Diabetes
Clin Diabetes 2010;28(4):157–162
https://doi.org/10.2337/diaclin.28.4.157
Published: 01 January 2010
View article titled, Application of Adult-Learning Principles to Patient Instructions: A Usability Study for an Exenatide Once-Weekly Injection Device
Open the PDF for Application of Adult-Learning Principles to Patient Instructions: A Usability Study for an Exenatide Once-Weekly Injection Device in another window
Journal Articles

Change as a Constant

Free
Tom Elasy, MD, MPH
Journal: Clinical Diabetes
Clin Diabetes 2008;26(2):49–50
https://doi.org/10.2337/diaclin.26.2.49
Published: 01 April 2008
View article titled, Change as a Constant
Open the PDF for Change as a Constant in another window
Journal Articles

Challenges of Managing Diabetes in Commercial Truck Drivers

Free
Jeremy B. Soule, MD, Leonard E. Egede, MD, MS
Journal: Clinical Diabetes
Clin Diabetes 2007;25(3):110–111
https://doi.org/10.2337/diaclin.25.3.110
Published: 01 July 2007
View article titled, Challenges of Managing Diabetes in Commercial Truck Drivers
Open the PDF for Challenges of Managing Diabetes in Commercial Truck Drivers in another window
Journal Articles

Glucagon-Like Peptide 1-Based Therapies for Type 2 Diabetes: A Focus on Exenatide

Free
Kathleen Dungan, MD, John B. Buse, MD, PhD
Journal: Clinical Diabetes
Clin Diabetes 2005;23(2):56–62
https://doi.org/10.2337/diaclin.23.2.56
Published: 01 April 2005
View article titled, Glucagon-Like Peptide 1-Based Therapies for Type 2 Diabetes: A Focus on Exenatide
Open the PDF for Glucagon-Like Peptide 1-Based Therapies for Type 2 Diabetes: A Focus on Exenatide in another window